See Remarks
See Remarks at Spyre Therapeutics, Inc., filing insider transactions between 2026-09-01 and 2026-10-01.
| SEC ↗ |
| 2026-10-01 | SYRE | Sale | 2,600 | $93.46 | $243K | SEC ↗ |
| 2026-10-01 | SYRE | Sale | 400 | $89.24 | $36K | SEC ↗ |
| 2026-09-02 | SYRE | Sale | 400 | $90.00 | $36K | SEC ↗ |
| 2026-09-01 | SYRE | Sale | 16.5K | $87.20 | $1.4M | SEC ↗ |
| 2026-09-01 | SYRE | Sale | 400 | $89.38 | $36K | SEC ↗ |
| 2026-09-01 | SYRE | Sale | 4,845 | $86.40 | $419K | SEC ↗ |
| 2026-09-01 | SYRE | Sale | 6,206 | $88.17 | $547K | SEC ↗ |